Oncimmune Holdings PLC (AIM:ONC) Adam Hill talks to Proactive about their momentum moving into the second quarter of the financial year to April 2022.
The autoantibody profiling service developed a pipeline of over 160 commercial opportunities last financial year and continues to secure follow-on contracts with customers of strategic importance.
Hill says these will support revenue growth in the current financial year.